These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8037359)
1. A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom. Wilson AB; Deighton J; Lachmann PJ; Ewan PW Allergy; 1994 Apr; 49(4):272-80. PubMed ID: 8037359 [TBL] [Abstract][Full Text] [Related]
2. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Ewan PW; Deighton J; Wilson AB; Lachmann PJ Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268 [TBL] [Abstract][Full Text] [Related]
3. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy. Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233 [TBL] [Abstract][Full Text] [Related]
4. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies. Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683 [TBL] [Abstract][Full Text] [Related]
5. Rush hymenoptera venom immunotherapy is efficacious and safe. Pasaoglu G; Sin BA; Misirligil Z J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of specific IgG antibodies in insect sting allergy. Urbanek R; Forster J; Karitzky D; Ziupa J Eur J Pediatr; 1981 Mar; 136(1):31-4. PubMed ID: 7215389 [TBL] [Abstract][Full Text] [Related]
7. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children. Varga EM; Francis JN; Zach MS; Klunker S; Aberer W; Durham SR Clin Exp Allergy; 2009 Sep; 39(9):1353-7. PubMed ID: 19538349 [TBL] [Abstract][Full Text] [Related]
8. Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects. Arzt L; Bokanovic D; Schrautzer C; Laipold K; Möbs C; Pfützner W; Herzog SA; Vollmann J; Reider N; Bohle B; Aberer W; Sturm GJ Allergy; 2018 Jun; 73(6):1223-1231. PubMed ID: 29171032 [TBL] [Abstract][Full Text] [Related]
9. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings]. Urbanek R; Dold S Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921 [TBL] [Abstract][Full Text] [Related]
10. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings? Sahiner UM; Durham SR Front Immunol; 2019; 10():1959. PubMed ID: 31497015 [TBL] [Abstract][Full Text] [Related]
11. Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio. Saulite I; Hoetzenecker W; Guenova E; Schmid-Grendelmeier P; Glatz M Int Arch Allergy Immunol; 2017; 174(3-4):190-199. PubMed ID: 29130986 [TBL] [Abstract][Full Text] [Related]
12. Natural history of Hymenoptera venom allergy in Eastern Spain. Fernandez J; Soriano V; Mayorga L; Mayor M Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189 [TBL] [Abstract][Full Text] [Related]
13. Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters. Malling HJ; Djurup R; Søndergaard I; Weeke B Allergy; 1985 Jul; 40(5):373-83. PubMed ID: 4037258 [TBL] [Abstract][Full Text] [Related]
14. [Allergy to insect stings. diagnosis and therapy (author's transl)]. Urbanek R Monatsschr Kinderheilkd (1902); 1980 Jan; 128(1):16-20. PubMed ID: 7360118 [TBL] [Abstract][Full Text] [Related]
15. Basophil sensitivity in patients not responding to venom immunotherapy. Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492 [TBL] [Abstract][Full Text] [Related]
16. Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression. Michils A; Mairesse M; Ledent C; Gossart B; Baldassarre S; Duchateau J J Allergy Clin Immunol; 1998 Jul; 102(1):118-26. PubMed ID: 9679855 [TBL] [Abstract][Full Text] [Related]
17. Sublingual desensitization in patients with wasp venom allergy: preliminary results. Patriarca G; Nucera E; Roncallo C; Aruanno A; Lombardo C; Decinti M; Pascolini L; Milani M; Buonomo A; Schiavino D Int J Immunopathol Pharmacol; 2008; 21(3):669-77. PubMed ID: 18831935 [TBL] [Abstract][Full Text] [Related]
18. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens. Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452 [TBL] [Abstract][Full Text] [Related]
20. Bee and wasp venom allergy in Turkey. Kalyoncu AF; Demir AU; Ozcan U; Ozkuyumcu C; Sahin AA; Bariş YI Ann Allergy Asthma Immunol; 1997 Apr; 78(4):408-12. PubMed ID: 9109709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]